Helping You Build Wealth With Honest Research
Since 1996. Try Now


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian Pharma and Healthcare Stocks

India is often referred to as the "pharmacy to the world", ranking third worldwide in total production volume and tenth by value.

As per National Indian Promotion Agency, it is the largest producer of generic medicines and vaccines, occupying 20% volume share in generics and 62% in vaccines.

Pharmaceutical spending in India is projected to grow over the next decade, leading India to become one of the top 10 countries in terms of medicine spending.

Increasing penetration of the health insurance and pharmacies is expected to drive expenditure on medicine.

For more details, check out our pharma sector report.

You can also check out Equitymaster's powerful stock screener to find the top pharma and healthcare companies in India.

This Pharma Company Just Declared a 1,800% Final Dividend

May 30, 2023

This pharma stock is rewarding shareholders with a hefty dividend of Rs 325 per share. Do you own it?

Why Divis Lab Share Price is Falling

May 19, 2023

Leading API manufacturer Divi's Labs has seen a sharp fall in its share price. What next?

Why Dr Reddy's Lab Share Price is Falling

May 12, 2023

Dr Reddy's Lab shares tumbled 5%, even after reporting a ten-fold jump in Q4 net profit. Here's why.

Top 5 Pharma Companies in India by Growth

Apr 30, 2023

China plus one, government's PLI scheme, and growing consumption are driving the growth of these five pharma companies.

Can the New Vaccine Rollout Change this Beaten Down Pharma MNC's Fortune in 2023?

Apr 26, 2023

This pharma MNC has just launched its global blockbuster vaccine in India. Will it be the turning point for this sleeping giant in 2023?

3 Caveats Before Considering the Mankind Pharma IPO

Apr 25, 2023

Every domestic pharma stock in India must contend with these woes.

Pharma Stocks: Is a Re-rating on the Cards?

Apr 20, 2023

Are the bitter days over for the Indian pharma sector? Here's what lies ahead.

2 Turnaround Stocks That Can Re Rate in 2023

Apr 7, 2023

A Travel and a Pharma Stock can be turnaround stories in 2023. Find out what factors can trigger a rerating in these stocks.

Specialty Chemical Company Slips 5% on Market Debut. More Details Inside...

Mar 22, 2023

This company recently concluded its IPO on the BSE SME segment where the issue price was set at Rs 73.

Next D-Mart Like Stock

Mar 14, 2023

Both growth and profitability can make this cost conscious business the next D-Mart.

Why Gland Pharma Share Price is Falling

May 23, 2023

Find out why Gland Pharma share price is bleeding on the bourses after its Q4 results.

Top 5 Stocks Mutual Funds Bought and Sold in April 2023

May 13, 2023

A look at what India's top equity mutual funds bought and sold in April 2023.

Why Sun Pharma Share Price is Falling

May 11, 2023

The company's shares have plummeted 5% in a month. More details inside.

Are Bitter Days Over for Pharma Stocks?

Apr 28, 2023

Has the pharma sector bottomed out? Find out as I decode the opportunity in the pharma sector.

Why Ipca Labs Share Price is Falling

Apr 25, 2023

Ipca Labs share price hits 52-week low after Unichem deal worth Rs 10 billion. How long before it recovers?

Don't Fall for the Trap in Pharma Stocks

Apr 24, 2023

Multiple technical factors indicate that investors should avoid pharma stocks in the current market. More details inside...

Mankind Pharma IPO: 5 Things to Know

Apr 18, 2023

The long-awaited Mankind Pharma IPO is opening soon. Find out key details inside.

5 Stocks to Watch Out for Bonus Shares and Stock Splits in April 2023

Mar 30, 2023

Here's the monthly bonus and stock split update. In April 2023, these five smallcap companies are either issuing bonus shares or undergoing a stock split.

20 High Potential Stocks to Start Your Momentum Journey

Mar 20, 2023

I'm opening the door to my first batch of 20 high potential momentum stocks.

Laurus or Divis? Here's What ChatGPT Had to Say

Mar 7, 2023

Rahul Shah asks ChatGPT whether Laurus is a better investment than Divis.